Mark A. Schlossberg

Mark A. Schlossberg

Plus aucun poste en cours

63 ans
Health Technology
Consumer Non-Durables
Consumer Services

Profil

Mark A.
Schlossberg
served as an Independent Director at ImmunoCellular Therapeutics Ltd.
from 2015 to 2017.
He was a Director at Angiologix, Inc. and a Vice President at Amgen, Inc. from 2004 to 2011.
He also worked as a Principal at R.J.
Reynolds Tobacco Holdings, Inc. and as a Vice President-Law at Medtronic Trading Ltd.
Additionally, he served as the Secretary, Senior Vice President & General Counsel at Impax Laboratories LLC from 2012 to 2018 and as the Secretary, Senior VP-Legal & General Counsel at Cytokinetics, Inc. from 2011 to 2022.
Schlossberg received his undergraduate degree from the University of Southern California and his graduate degree from Emory University School of Law.

Anciens postes connus de Mark A. Schlossberg

SociétésPosteFin
CYTOKINETICS, INCORPORATED Conseiller Juridique Général 13/05/2022
Conseiller Juridique Général 01/05/2018
EOM PHARMACEUTICALS HOLDINGS, INC. Directeur/Membre du Conseil 15/08/2017
AMGEN INC. Corporate Officer/Principal 01/05/2011
Corporate Officer/Principal -
Voir l'expérience en détail de Mark A. Schlossberg

Formation de Mark A. Schlossberg

University of Southern California Undergraduate Degree
Emory University School of Law Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mark A. Schlossberg

Relations

100 +

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
AMGEN INC.

Health Technology

CYTOKINETICS, INCORPORATED

Health Technology

Entreprise privées6

Consumer Non-Durables

Health Technology

Health Technology

Electronic Technology

Medtronic Trading Ltd.

Consumer Non-Durables

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mark A. Schlossberg
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT